In the search for new approaches to treat ERBB2 (also known as HER2) positive breast cancers that have become drug-resistant, Dartmouth's Norris Cotton Cancer Center investigator Manabu Kurokawa, PhD, led a team in discovery of a novel cancer resistance mechanism with findings published in Cell Cycle.
from The Medical News http://ift.tt/1F1I1fR
from The Medical News http://ift.tt/1F1I1fR
No comments:
Post a Comment